Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Benz

Showing results (291-300 of 489) with videos related to

Pageof 49
Sort By:
Journal of Cardiovascular Computed Tomography|January 13, 2016
Impact of monochromatic coronary computed tomography angiography from single-source dual-energy CT on coronary stenosis quantificationJulia Stehli, Olivier F Clerc, Tobias A Fuchs, et al.
Amino Acids|June 5, 2021
N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis propertiesGary K Scott, Sophia Mahoney, Madeleine Scott, et al.
Molecular Cancer Therapeutics|October 17, 2007
Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cellsAudrey Roth, Daryl C Drummond, Fraser Conrad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Protein acetylation and histone deacetylase expression associated with malignant breast cancer progressionJunko Suzuki, Yunn-Yi Chen, Gary K Scott, et al.
Annals of Surgical Oncology|November 15, 2006
Type and duration of exogenous hormone use affects breast cancer histologyAnjali S Kumar, Elizabeth Cureton, Veronica Shim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Investigational New Drugs|January 1, 1995
Developing gossypol derivatives with enhanced antitumor activityX S Liang, A J Rogers, C L Webber, et al.
Amino Acids|July 21, 2021
Correction to: N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis propertiesGary K Scott, Sophia Mahoney, Madeleine Scott, et al.
Breast Cancer Research : BCR|January 30, 2020
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survivalMustafa I Jaber, Bing Song, Clive Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomesDaryl C Drummond, Corina Marx, Zexiong Guo, et al.
Pageof 49

Showing results (291-300 of 489) with videos related to

Sort By:
Pageof 49
Journal of Cardiovascular Computed Tomography|January 13, 2016
Impact of monochromatic coronary computed tomography angiography from single-source dual-energy CT on coronary stenosis quantificationJulia Stehli, Olivier F Clerc, Tobias A Fuchs, et al.
Amino Acids|June 5, 2021
N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis propertiesGary K Scott, Sophia Mahoney, Madeleine Scott, et al.
Molecular Cancer Therapeutics|October 17, 2007
Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cellsAudrey Roth, Daryl C Drummond, Fraser Conrad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Protein acetylation and histone deacetylase expression associated with malignant breast cancer progressionJunko Suzuki, Yunn-Yi Chen, Gary K Scott, et al.
Annals of Surgical Oncology|November 15, 2006
Type and duration of exogenous hormone use affects breast cancer histologyAnjali S Kumar, Elizabeth Cureton, Veronica Shim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Investigational New Drugs|January 1, 1995
Developing gossypol derivatives with enhanced antitumor activityX S Liang, A J Rogers, C L Webber, et al.
Amino Acids|July 21, 2021
Correction to: N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis propertiesGary K Scott, Sophia Mahoney, Madeleine Scott, et al.
Breast Cancer Research : BCR|January 30, 2020
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survivalMustafa I Jaber, Bing Song, Clive Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomesDaryl C Drummond, Corina Marx, Zexiong Guo, et al.
Pageof 49